Open Medicine
(Aug 2021)
Prognostic value of microRNA-4521 in non-small cell lung cancer and its regulatory effect on tumor progression
Sun Butong,
Cong Dan,
Chen Kang,
Bai Yuansong,
Li Jun
Affiliations
Sun Butong
Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China
Cong Dan
Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China
Chen Kang
Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China
Bai Yuansong
Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun, Jilin, 130031, China
Li Jun
Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun, Jilin, 130031, China
DOI
https://doi.org/10.1515/med-2021-0312
Journal volume & issue
Vol. 16,
no. 1
Abstract
Read online
Non-small cell lung cancer (NSCLC) is a malignant tumor with the highest mortality rate in our country. It has been found in many studies that microRNA-4521 (miR-4521) is abnormally expressed and plays a role in clear cell renal cell carcinoma and other cancers.
Keywords
WeChat QR code
Close
